Home
VISUfarma

VISUfarma Market Share Analysis for February 2026

Find out how to contact your local VISUfarma product distributor here, or if you would like to learn more about becoming an international distributor of our eye health products, please complete the form available here and submit it to us.

Industry: N/A

Domainvisufarma.com

Year Founded2016

Employees51 - 200

Annual Revenue$50M - $75M

VISUfarma

VISUfarma (including company regionals)

visufarma.com

See more website traffic and engagement information

VISUfarma Revenue up to February 2026 is 50M - 75M

revenue generated by VISUfarma top domains

VISUfarma top domains revenue over 3 years

Revenue for VISUfarma top domains

visufarma.com50M - 75M

See more with Sales Intelligence

Total visits to VISUfarma's top domains

Understand VISUfarma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

visufarma.com6.5K

See more with Sales Intelligence

Avg. visit duration in VISUfarma's top domains

Analyze VISUfarma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

visufarma.com00:00:20

See more with Sales Intelligence

Avg. pageviews on VISUfarma's top domains

See how VISUfarma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

visufarma.com1.76

See more with Sales Intelligence

VISUfarma top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by VISUfarma

These are the website technologies, by industry, used by VISUfarma top domains

Advertising (5)

DoubleClick

Widget (4)

Twemoji

Payment & Currencies (3)

Euro

Social (3)

Instagram

More Technologies

8

See all

News & Signals from VISUfarma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLupin Pharmaceuticals, Inc. is planning to acquire VISUfarma SAS.Global pharmaceutical company Lupin Limited (BSE: 500257, NSE: LUPIN) has signed a definitive agreement to acquire VISUfarma B.V., a Netherlands-based specialty pharmaceutical player focused on ophthalmology, from private equity investor GHO Capital Partners LLP.

NewsNanomi was planning to acquire VISUfarma SAS on Dec 31st '25.The transaction will involve Lupin's Dutch subsidiary Nanomi acquiring VISUfarma, with the deal expected to be closed by the end of this year.

NewsVISUfarma SAS launches Xailin Ectoine.VISUfarma are launching Xailin(R) Ectoine eye drops: for the symptomatic relief of red, itchy, watery and burning eyes caused by year-round allergy-related irritation and dryness, in a preservative and phosphate free formulation.